Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity

Kryslaine O Lopes1, D Larry Sparks, Wolfgang J Streit

  • 1Department of Neuroscience, University of Florida College of Medicine, Gainesville, Florida 32610-0244, USA.

Glia
|April 30, 2008
PubMed

Insights

Degenerating microglial cells, identified by ferritin, are linked to aging and Alzheimer's disease (AD). This suggests iron metabolism contributes to microglial damage, offering a new detection method for neurodegeneration.

Area of Science:

  • Neuroscience
  • Neuropathology
  • Cell Biology

Background:

  • Microglial cell degeneration is implicated in aging-related neurodegeneration and Alzheimer's disease (AD).
  • Iron accumulation in aging brains may exacerbate oxidative stress, impacting cellular health.
  • Microglia play a crucial role in brain immune responses and iron homeostasis.

Purpose of the Study:

  • To investigate the role of ferritin, an iron storage protein, in microglial degeneration in aging and AD brains.
  • To determine if increased ferritin expression makes microglia more susceptible to damage.
  • To explore ferritin immunohistochemistry as a marker for degenerating microglia.

Main Methods:

  • Analysis of microglial morphology in non-demented and AD human brain tissue using ferritin immunohistochemistry.
  • Identification of ferritin-positive microglia within the broader microglial population (HLA-DR+).
  • Assessment of microglial dystrophy in relation to age, AD status, and postmortem interval (PMI).

Main Results:

  • Ferritin-positive microglia were identified as a subpopulation with distinct morphological changes (dystrophy) in aged and AD brains.
  • Microglial dystrophy was observed in aged and AD brains, independent of proximity to senile plaques.
  • The occurrence of microglial dystrophy was not influenced by postmortem interval, ruling out autolysis as a cause.

Conclusions:

  • Microglial iron storage and metabolism, indicated by ferritin, contribute to cell degeneration, likely via oxidative stress.
  • Ferritin immunohistochemistry is a potential method for identifying degenerating microglia in human brain tissue.
  • Understanding microglial degeneration is key to unraveling neurodegenerative disease pathogenesis.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...